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Dissociable Effects of Tryptophan
Supplementation on Negative
Feedback Sensitivity and Reversal
Learning
Martin Thirkettle, Laura-Marie Barker , Thomas Gallagher , Nazgol Nayeb and Luca Aquili*
Department of Psychology, Sociology and Politics, Sheffield Hallam University, Sheffield, United Kingdom
Serotonin has been shown to modulate probabilistic reversal learning (PRL) and negative
feedback sensitivity (NFS) in both animal and human studies. Whilst these two measures
are tightly coupled, some studies have suggested that these may be mediated by
independent mechanisms; the former, representing perseveration and cognitive flexibility,
and the latter measuring the ability to maintain a response set (win-stay) at the expense
of lose-shift behavior when occasional misleading feedback has been presented. Here,
we tested this hypothesis in 44 healthy participants who were administered tryptophan
(22 placebo, 22 tryptophan), a precursor to serotonin. We found a dissociable effect
of tryptophan supplementation on PRL/NFS. Specifically, tryptophan administration
increased NFS compared to the placebo group but had no effect on PRL. We discuss
these findings in relation to dosages and with a particular focus on the acute tryptophan
depletion (ATD) procedures.
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INTRODUCTION
Serotonin (5-HT) has long been implicated in probabilistic reversal learning (PRL) and in
processing negative feedback. Both are measured by the PRL task, originally developed in humans
(Cools et al., 2002), but then also adapted in animal studies (Bari et al., 2010; Ineichen et al., 2012).
In this task, the subject is instructed to choose one of two visual stimuli in order to maximize
correct feedback/rewards. Once a certain number of correct responses are made, stimulus-reward
contingencies are reversed. Additionally, for a minority of trials (usually 20%), misleading feedback
is provided to a normally rewarded response. Negative feedback sensitivity (NFS) is defined as the
frequency for which responses shift to the usually non-rewarded choice on such trials. Depressed
patients, who are known to have impaired serotonergic function, display normal PRL but higher
NFS compared to healthy subjects (Murphy et al., 2003; Taylor Tavares et al., 2008), suggesting
that at least behaviorally, these two processes can be decoupled. This effect also appears to be dose
and acute/chronic administration dependent; low (acute: 1 mg/kg) doses of the selective serotonin
reuptake inhibitor (SSRI) citalopram in rats impaired PRL and increased NFS, whereas high (acute;
10 mg/kg) doses produced the opposite effect. In the same study, chronic high doses (5 mg/kg,
daily, 7 days), in contrast, improved PRL but did not affect NFS (Bari et al., 2010; Robbins, 2017).
Abbreviations: ATD, acute tryptophan depletion; NFS, negative feedback sensitivity; PRL, probabilistic reversal learning;
SERT, serotonin transporter; SSRI, serotonin reuptake inhibitor; VAS, visual analog scale; 5-HT, serotonin.
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Similar findings for low acute doses of citalopram (30 mg) have
also been reported in humans (Chamberlain et al., 2006). Using
a different SSRI in rats, escitalopram, all doses (0.03, 0.3 or
1.0 mg/kg) improved PRL but left NFS unaffected (Brown et al.,
2012). These findings may partially be explained by the slightly
different characteristics of citalopram and escitalopram. Whilst
both have similar pharmacokinetics, escitalopram has higher
potency and selectivity than citalopram (Carandang et al., 2011).
There is also some evidence to suggest that polymorphisms in
the gene encoding the serotonin transporter (SERT) can affect
NFS and PRL differentially. In this study (den Ouden et al.,
2013), individuals who were L’-homozygotes (i.e., decreased
levels of extracellular serotonin) had higher NFS than S’ carriers
whilst there was no PRL performance difference between these
two groups. It is important, nevertheless, to stress that the
association between the SERT promoter polymorphism and
depression has not been confirmed by a recent meta-analysis
(Culverhouse et al., 2018), and may suggest a more complex
interaction (Rygula et al., 2018). Studies using the acute
tryptophan depletion (ATD) procedure have produced mixed
results. Some have reported no effect on PRL (but NFS was
not investigated; Evers et al., 2005; Talbot et al., 2006; Finger
et al., 2007; van der Plasse and Feenstra, 2008), whereas in
others ATD impaired PRL (Murphy et al., 2002). Overall, the
studies reviewed on depressed patients, SSRI administration
and ATD suggest a potential inverted U-shaped relationship
between serotonin concentration and NFS/PRL whereby too
low or high 5-HT levels impair performance (Hulsken et al.,
2013). Interestingly, a similar relationship has long been
reported for the other monoamine neurotransmitter, dopamine
(Cools and D’Esposito, 2011).
Here, using a double-blind, placebo-controlled, mixed-design
method, we hypothesized that tryptophan supplementation
may selectively affect NSF but leave PRL performance intact.
Although numerous studies have looked at tryptophan’s
modulation of memory, response to unfairness, emotional
processing, attention and executive function (Sobczak et al., 2003;
Booij et al., 2006; Murphy et al., 2006; Dougherty et al., 2007;
Morgan et al., 2007; Silber and Schmitt, 2010; Cerit et al., 2015;
Mohajeri et al., 2015), to the best of our knowledge, this is the
first study looking at its effects on PRL and NFS.
MATERIALS AND METHODS
Participants
Participants consisted of 44 university students, who were either
administered tryptophan (N = 22,M = 21.4, SD = 3.0, 13 females
and nine males) or placebo (N = 22, M = 20.8, SD = 2.6,
15 females and seven males). The study was approved by the
ethics committee of Sheffield Hallam University and complied
with the Declaration of Helsinki. Written informed consent was
obtained for all participants before testing could take place.
Exclusion criteria included: those suffering from cardiac, hepatic,
renal and neurological disorders and individuals with a history
of alcohol or drug addiction, or psychiatric illness (including
individuals who had a history of taking antidepressants).
Individuals having a history of taking tryptophan supplements
were also excluded.
Drug Administration
Participants received either 0.8 grams of Tryptophan (supplied
by BulkPowders Ltd., Colchester, UK) or 0.8 grams of
microcrystalline cellulose (Sigma-Aldrich Co. LLC., St.
Louis, MO, USA) dissolved in 200 ml of orange juice as
per previously published protocols (Steenbergen et al.,
2014). Peak plasma concentrations of tryptophan using this
dosage have been shown to occur 60 min following oral
administration (Markus et al., 2008).
Probabilistic Reversal Learning Task
To assess NFS and reversal learning, we used the PRL paradigm
developed by Cools et al. (2002) and which runs in PEBL software
(Mueller and Piper, 2014). Here, using trial-and-error feedback,
participants need to discover which of two patterns is correct
(see Figure 1). To complete the PRL, participants had to finish
one block of trials, consisting of 10 reversals. Each block had
approximately 150 trials. Each reversal occurred after a variable
10–15 correct responses (including probabilistic errors: here
defined as misleading feedback provided to the usually correct
and rewarded response). The number of probabilistic errors
per reversal varied between 0 and 4. The task was self-paced
meaning that there was no timeout period to produce a response
in each trial, however, participants were asked to respond as
quickly and accurately as possible. Participants were given a
full block of practice trials before testing began. We measured
the following dependent measures: total errors, reversal errors
and NFS. Total errors were made up of incorrect responses
occurring before and after each reversal. Reversal errors were
counted as the number of incorrect responses after each reversal
and before the first correct response following a reversal.
NFS was measured by calculating the probability (measured
in %) of switching a response following the presentation of
misleading negative feedback (i.e., no reward), which occurs in
a low proportion of trials. Thus, NFS was high if participants
switched response following negative misleading feedback
(i.e., lose-shift behavior) and low if participants maintained the
usually rewarded option following negative misleading feedback
(i.e., lose-stay behavior). See Figure 1 for an illustration of
the PRL task.
Control Measures: Mood and
Double-Blinding Efficacy
Transient changes in mood state have been demonstrated
to influence cognitive functioning (Federmeier et al., 2001),
and of particular relevance to this research, probabilistic
learning (Bakic et al., 2014). Therefore, we checked for the
potential mood effects induced by tryptophan intake on PRL
by administering a computerized adaptation of the visual
analog scale (VAS) which was programmed and run in PEBL
(Mueller and Piper, 2014), and has previously been used by
our research group (Ong Lai Teik et al., 2016; Riby et al.,
2017). Seven dimensions of mood/alertness were, recorded
with a total minimum score of 7 (low mood/alertness) and
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FIGURE 1 | Schematic illustration of probabilistic reversal learning task (PRL) which ran in PEBL. Adapted from Cools et al. (2002). Each pairs of stimuli [i.e., a
yellow circle with a green cross and a blue rectangle (here defined as stimulus 1) or a blue oval, a red star and a brown square (here defined as stimulus 2)] represent
a trial. Responses (here indicated by a blue arrow next to one of the two stimuli) can either be correct (green smiley feedback face) or incorrect (red frowny feedback
face). In a small subset of trials (i.e., <20%), misleading feedback (probabilistic error) is provided to the usually correct and rewarded response (e.g., in this instance,
after two correct responses to stimulus 1, the participant is provided with misleading feedback on trial 3). Negative feedback sensitivity (NFS) is measured (in the
example above, NFS is measured on the 4th trial) by looking at whether participants stick to the usually rewarded response following negative misleading feedback
(lose-stay) or switch (lose-shift). Response reversals (n = 10 × 1 block of trials) are required after a series of correct responses.
a maximum total score of 147 (high mood/alertness). The
double-blinding efficacy of placebo/tryptophan administration
was checked by a questionnaire given to participants at the end
of the experiment.
Procedure
This was a double-blind, placebo-controlled, mixed design
experiment. Participants were required to attend a session lasting
approximately 70 min. After screening for eligibility, participants
were instructed to refrain from eating/drinking for a minimum
of 3 h. They first signed a consent form, followed by the mood
questionnaire (VAS; time 1), and were then asked to complete
two blocks of the (PRL time 1). They were then randomly
assigned to receive either tryptophan or placebo. Sixty minutes
following tryptophan intake which corresponds to peak plasma
concentration (Markus et al., 2008) or placebo, the VAS and PRL
were completed for a second time (VAS time 2; PRL time 2).
Following this, participants filled out the tryptophan/placebo
double-blind questionnaire, and were debriefed.
Statistical Analyses
Statistical analyses were performed using SPSS version 23 (SPSS
Inc., Chicago, IL, USA). Sample size was chosen to deliver
power at 0.8, an alpha level set at 0.05, and a large effect size
(d) of 0.8 (G∗Power 3.1.9.2, Germany). For all the dependent
measures of the PRL, we first run an independent sample t-test at
baseline (time 1), between placebo and tryptophan participants.
If there was no significant performance difference at baseline, we
calculated a percentage change at time 2 compared with time 1,
and used these new values to compare placebo with tryptophan
using another independent sample t-test. A full breakdown of the
raw data is shown in Table 1.
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TABLE 1 | Mean and SD (in brackets) for negative feedback sensitivity (NFS), reversal errors and total errors in placebo and tryptophan participants.
Group NFS (%) Reversal errors Total errors
Placebo (pre-drug) 48.71 (6.5) 18.20 (6.3) 80.30 (35.6)
Placebo (post-drug) 43.23 (8.2) 17.47 (3.5) 63.68 (31.4)
Tryptophan (pre-drug) 46.34 (4.5) 20.31 (7.0) 76.80 (23.4)
Tryptophan (post-drug) 46.36 (6.1) 17.43 (4.9) 71.00 (35.2)
FIGURE 2 | (A) Percentage change from baseline (time 2/time 1) for placebo and tryptophan participants with respect to NFS performance. NFS was significantly
higher when comparing tryptophan to placebo participants. (B) As for (A). There was no significant difference between the two groups on reversal learning errors.
(C) As for (A,B). There was no significant difference between placebo and tryptophan participants on total errors. ∗∗∗ Indicates p < 0.01. Error bars as standard error
of the mean (SEM).
Mood data were analyzed using a two-way factorial repeated
measures analysis of variance (ANOVA), where the factor of
Time had two levels (VAS 1–2) and drugs had two (placebo
and tryptophan).
The double blinding efficacy of tryptophan/placebo was
analyzed using a percentage correct measure. A score of 100 was
given if a participant correctly identified condition whereas a
score of 0 if not.
RESULTS
PRL Negative Feedback Sensitivity (NFS)
To assess the impact of tryptophan administration on NFS, we
first took a measurement at baseline (i.e., prior to drug intake).
There was no significant difference in NFS performance between
placebo and tryptophan participants, t(42) = −1.38, p = 0.172,
d = 0.41. Therefore, we calculated a change in performance,
expressed in percentage, from time 2 (after drug intake) to time
1 (before drug intake; as in time 2/time 1).
Here, whilst there was a reduction in NFS between time
1 and time 2 for placebo participants, tryptophan abolished
this change. As a result, NFS was significantly higher for
tryptophan than placebo participants, t(42) = −2.80, p = 0.008,
d = 0.84, see Figure 2A.
PRL Reversal Learning Errors
The same analyses were applied for reversal learning errors.
At baseline, there was no significant difference in performance
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between placebo and tryptophan participants, t(42) = −1.04,
p = 0.301, d = 0.31.
Both placebo and tryptophan participants improved from
baseline. This change in performance from post-drug to
pre-drug was not significantly different between the two groups,
t(42) =−1.33, p = 0.188, d = 0.40, see Figure 2B.
PRL Total Errors
As for NFS and reversal learning errors, there was no significant
difference between placebo and tryptophan participants at
baseline, t(42) = 0.34, p = 0.703, d = 0.11. Tryptophan, also did
not affect changes in performance from baseline, t(42) = 1.21,
p = 0.231, d = 0.36, see Figure 2C.
Changes in Reversal Errors Are
Independent of Changes in NFS
To confirm that NFS and reversal errors provide separate
measures of performance, we run a bivariate correlation analysis
between the variables reversal errors (measured as a change
in performance from pre-drug to post-drug) and NFS (also
measured as a change in performance). There was no significant
correlation between reversal errors and NFS, r = 0.05, p = 0.701,
see Figure 3.
Control Measures: Mood and Double
Blinding Efficacy
There was neither a significant main effect of time, F(1,42) = 1.04,
p = 0.313 onmood scores nor amain effect of drugs, F(1,42) = 1.45,
p = 0.234, nor a drugs× time interaction, F(1,42) = 0.81, p = 0.373.
The probability of participants guessing the correct drug (placebo
or tryptophan) was at about chance level (56%).
DISCUSSION
We report a selective effect of tryptophan supplementation on
NFS but not on PRL. Whereas for participants in the placebo
group their NFS decreased from pre-drug administration to
post-drug (due to a practice effect), tryptophan suppressed
this reduction. This had the net effect that NFS was higher
for participants in the tryptophan condition than the placebo
controls (i.e., when measured as a change in performance from
baseline to post-drug administration). PRL (reversal errors) and
total errors performance, however, was unaffected. Exploratory
analyses (i.e., Figure 3), confirm that reversal errors and NFS are
dissociated from one another. The observation that reversal and
total errors decreased for the tryptophan group from pre-drug
to post-drug but NFS did not, demonstrates that tryptophan did
not affect the overall acquisition of the task but inhibited NFS
learning specifically.
This finding is in line with the tryptophan depletion
studies (Evers et al., 2005; Talbot et al., 2006; Finger et al.,
2007; van der Plasse and Feenstra, 2008), and suggest that
reducing or increasing serotonin, in humans, does not modulate
reversal learning. Nevertheless, global serotonin (5-HT) or
prefrontal cortex depletion studies in animals and manipulations
of serotonin postsynaptically by SSRI (in both animals and
humans) demonstrate that serotonin can affect reversal learning
FIGURE 3 | Correlation scatterplot for the variables reversal errors (Y axis)
and NFS (X axis) across participants. X and Y values represent a percentage
change (%) from baseline (i.e., before drug) to after tryptophan or placebo
intake. + for Reversal Errors indicate a reduction in errors, whereas + for NFS
equals an increase in NFS.
(Clarke et al., 2004, 2005; Chamberlain et al., 2006; Bari et al.,
2010; Brown et al., 2012), as do studies that target 5-HT receptors
(Boulougouris et al., 2008).
Our finding that tryptophan supplementation increased NFS
is similar to some reports in which small (but not large)
doses of SSRI were administered (Chamberlain et al., 2006;
Bari et al., 2010). Interestingly, our data support the idea of
a dissociation between PRL and NFS performance as reported
in depressed patients and those with serotonergic transporter
polymorphisms (Murphy et al., 2003; Taylor Tavares et al.,
2008; den Ouden et al., 2013), supporting the view that
the PRL is a broader measure of cognitive flexibility than
NFS which isolates sensitivity to negative feedback. To this
end, ATD studies have highlighted a role for serotonin in
aversive processing and punishment prediction (Cools et al.,
2008; Robinson et al., 2012). In conclusion, our data provide
preliminary evidence for a role of tryptophan supplementation
on NFS, an effect that is independent of reversal learning.
The current study adds to a complex picture in which
general serotonergic activity manipulations, SERT promoter
polymorphisms, SSRI administration and targeting of 5-HT
receptors, differentially affect NFS and PRL. Future studies
that address the SSRI equivalence of the applied tryptophan
dosage and its effects on 5-HT levels would be critical,
taking into account respective non-linear effects. Although
tryptophan supplementation on its own is not going to replace
SSRI usage at a therapeutic level, finding out the optimal
dosage may support cognitive performance with little to no
side effects.
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